Curing nervous system diseases remains speculative. Only careful research is likely to clarify if all conditions can be cured or if a cure is only possible in certain cases. Although many people believe that they can cure nervous system conditions, in truth, even if treatment is successful and only temporary symptoms are temporarily alleviated, they will still have to accept that there is no cure.
Nervous system diseases are divided into central nervous system diseases (CNS), peripheral nervous system diseases (PNS), skin and integumentary diseases and other miscellaneous illnesses. Signs of CNS diseases include blurred vision with or without double vision, slurred speech, headaches, altered mental status and, rarely, seizures. Of the PNS signs, the most common is neurogenic bowel, which may manifest itself as cramping abdominal pain, constipation or diarrhea. Skin and integumentary signs that are not neurological signs include anhidrosis, a cold or dry and itchy rash, itching or rash on parts of the body not usually exposed to the sun (e.g.
This analysis suggests a substantial number of new cases of many neuropsychiatric disorders should occur annually in the U.S. The large, national sample can be used as a baseline when evaluating surveillance data in the U.S. for neurodevelopmental disorders.
The causes of nervous system diseases may include several factors that do not appear to be purely genetic. Damage to the brain or spinal cord due to traumatic head injury, systemic diseases such as malaria, or chronic drug misuse can precipitate neurological change.
For many nervous system diseases, there is no cure, so treatments focus on symptom management, such as pain management or medications, to help decrease side effects. In this article, common treatments for each nervous system disorder will be discussed.
This is a review of current knowledge of neural health promotion and disease management based on clinical research evidence and literature review. This article discusses the recent advances in neurology and neurosurgery treatment, along with the role of the clinician on promoting a healthy lifestyle for all people, even those who have been diagnosed with these common psychiatric diseases and neurological conditions.
EES is a novel noninvasive treatment method which has been used successfully to treat patients suffering from various neuropathic or inflammatory conditions, and has shown potential to be a useful and alternative therapeutic procedure for clinical use. It is also possible that future research could result in the development of innovative therapeutic protocols for future clinical use to treat a variety of central and peripheral neuropathic conditions for which the spinal cord offers an ideal neural pathway. However, further experimentation is warranted to assess the potential for use of EES as a method for spinal cord functional recovery as a result of multiple sclerosis.
Although more than 10% of people are thought to develop some disease attributable to mental illness or physical disability during their lifetimes, the vast majority of these people may have no first-hand, family experiences with such mental or physical problems. Although the familial transmission of a disease from one generation to the next is well known, the transmission through more than one generation has received scant attention. The possible contribution from this experience to present diagnoses needs to be examined.
Findings from a recent study of an investigation into the effects of ees on the sensory thresholds of the hindlimb of rats with chronic constriction injury indicate that ees may exert analgesic effects by enhancing the descending excitatory mechanisms of the spinoreticular system, but may not restore normal gait in rats with a surgically induced leg injury. If ees could be effective in relieving the pain associated with peripheral neuropathies of human origin, it may be feasible to demonstrate the benefits of ees for the treatment of these disorders.
There is no clear-cut cutoff number for the severity of a disease that will result in certain outcomes. However, there are definite features that indicate that certain people are more or less likely to develop a serious complication. For some of the diseases, a simple cutoff number in the disease course in time is not accurate to estimate the outcome. While not all neurological diseases can cause a similar clinical course, they are more likely to result in a permanent and permanent condition. Some neurological disorders are most likely to result in certain outcomes (e.g., dementia), or those with a more severe disease course. At least some neurological conditions are associated with a significant morbidity or even life expectancy.
Although the number of subjects was small, our findings indicate that EES may be associated with only mild side effects, but more studies with larger number of subjects are needed. It is possible that the duration of the electrical pulses may be too short for long-term application. Further research is necessary to investigate the efficacy and safety of long-term EES and other forms of repetitive electrical stimulation.